BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1485881)

  • 1. Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida: effects of dilution, iron chelation, and heterologous challenge.
    Ficken MD; Barnes HJ; Avakian AP; Carver DK
    Avian Dis; 1992; 36(4):975-85. PubMed ID: 1485881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida: effects of ultrafiltration and endotoxin removal.
    Ficken MD; Barnes HJ; Avakian AP; Carver DK
    Avian Dis; 1992; 36(2):423-31. PubMed ID: 1627112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of turkeys with cell-free culture filtrate of Pasteurella multocida.
    Ficken MD; Barnes HJ; Qureshi MA
    Avian Dis; 1991; 35(1):126-34. PubMed ID: 2029246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection studies with Pasteurella multocida bacterins prepared from bacteria propagated in iron-depleted medium.
    Glisson JR; Contreras MD; Cheng IH; Wang C
    Avian Dis; 1993; 37(4):1074-9. PubMed ID: 8141736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive cross-protection provided by antisera directed against in-vivo-expressed antigens of Pasteurella multocida.
    Wang C; Glisson JR
    Avian Dis; 1994; 38(3):506-14. PubMed ID: 7832703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated live fowl cholera vaccine. I. Development of vaccine strain M3G of Pasteurella multocida.
    Hertman I; Markenson J; Michael A; Geier E
    Avian Dis; 1979; 23(4):863-9. PubMed ID: 546409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA, IgG, and anti-Pasteurella multocida antibody levels in bursectomized and/or cyclophosphamide-treated turkeys after CU vaccination.
    Schlink GT; Olson LD; Saif YM; Jackwood DJ
    Avian Dis; 1993; 37(3):668-72. PubMed ID: 8257356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Pasteurella multocida mutants of low virulence. II. Immunologic response of turkeys.
    Hofacre CL; Glisson JR; Kleven SH
    Avian Dis; 1989; 33(2):275-8. PubMed ID: 2751560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys.
    Hopkins BA; Olson LD
    Avian Dis; 1997; 41(2):317-25. PubMed ID: 9201394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bacterin against fowl cholera in turkeys: protective quality of various preparations originated from broth cultures.
    Matsumoto M; Helfer DH
    Avian Dis; 1977; 21(3):382-93. PubMed ID: 907580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysates of turkey-grown Pasteurella multocida: effects of solubilizing agents on the immunologic properties of membrane vesicles.
    Brogden KA; Rimler RB
    Am J Vet Res; 1983 Mar; 44(3):428-32. PubMed ID: 6838037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of medicated turkeys vaccinated with live Pasteurella multocida.
    Derieux WT
    Am J Vet Res; 1977 Apr; 38(4):487-9. PubMed ID: 851281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of two live Pasteurella multocida aro-A mutant vaccines in chickens.
    Scott PC; Markham JF; Whithear KG
    Avian Dis; 1999; 43(1):83-8. PubMed ID: 10216763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of a cross-protective antigen from Pasteurella multocida grown in vitro and in vivo.
    Rimler RB
    Avian Dis; 2001; 45(3):572-80. PubMed ID: 11569729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysates of turkey-grown Pasteurella multocida: protection against homologous and heterologous serotype challenge exposures.
    Rimler RB; Rhoades KR
    Am J Vet Res; 1981 Dec; 42(12):2117-21. PubMed ID: 6803619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between anti-Pasteurella multocida antibody titers after CU vaccination and survival after challenge.
    Schlink GT; Olson LD
    Avian Dis; 1989; 33(3):506-10. PubMed ID: 2775097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Pasteurella multocida mutants of low virulence. I. Development and pathogenicity.
    Hofacre CL; Glisson JR; Kleven SH; Brown J; Rowland GN
    Avian Dis; 1989; 33(2):270-4. PubMed ID: 2751559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterin-induced protection of turkeys against fowl cholera following infection with Bordetella avium.
    Rimler RB; Kunkle RA
    Avian Dis; 1998; 42(4):752-6. PubMed ID: 9876844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection factor(s) of Pasteurella multocida: passive immunization of turkeys against fowl cholera caused by different serotypes.
    Rimler RB
    Avian Dis; 1987; 31(4):884-7. PubMed ID: 3442539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of live avirulent M-9, Minnesota, and CU fowl cholera vaccines.
    Friedlander RC; Olson LD; McCune EL
    Avian Dis; 1991; 35(2):251-6. PubMed ID: 1854311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.